Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial-Reference-Cited by-同舟云学术

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

Published:2022-12 Issue:10367 Volume:400 Page:1938-1952
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Mebazaa Alexandre,Davison Beth,Chioncel Ovidiu,Cohen-Solal Alain,Diaz Rafael,Filippatos Gerasimos,Metra Marco,Ponikowski Piotr,Sliwa Karen,Voors Adriaan A,Edwards Christopher,Novosadova Maria,Takagi Koji,Damasceno Albertino,Saidu Hadiza,Gayat Etienne,Pang Peter S,Celutkiene Jelena,Cotter Gad

Funder

Roche Diagnostics Corp

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry;Chioncel;Eur J Heart Fail,2017

2. Health system-level performance in prescribing guideline-directed medical therapy for patients with heart failure with reduced ejection fraction: results from the CONNECT-HF trial;Granger;J Card Fail,2022

3. Treatment patterns and clinical outcomes among patients <65 years with a worsening heart failure event;Butler;Eur J Heart Fail,2021

4. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry;Greene;J Am Coll Cardiol,2018

5. The Cardiology Society of India-Kerala Acute Heart Failure Registry: poor adherence to guideline-directed medical therapy;Joseph;Eur Heart J,2021

Cited by 412 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker;Heart Failure Clinics;2024-10

2. In-hospital initiation of sodium-glucose cotransporter-2 inhibitors in patients with heart failure and reduced ejection fraction: 90-day prescription patterns and clinical implications;Current Problems in Cardiology;2024-10

3. Atención primaria y péptidos natriuréticos: diseño de un proceso asistencial para la mejora en el diagnóstico de la insuficiencia cardiaca;Medicina de Familia. SEMERGEN;2024-10

4. The War Against Heart Failure Hospitalizations;Heart Failure Clinics;2024-10

5. Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?;Heart Failure Clinics;2024-10